Foetal head growth retardation due to antiepileptic drugs: with reference to GH, TSH, T4, T3 and reverse T3 concentrations. 1983

S Kaneko, and T Hirano, and Y Fukushima, and T Sato, and Y Nomura, and S Shinagawa, and Y Ogawa

To study the mechanisms of inhibitory action of antiepileptic drugs on foetal head growth, determinations were made of the growth hormone, thyrotropin and thyroid hormone levels in the sera of pregnant women, and the correlations between each hormone concentration and the foetal head circumference were studied. The thyroxine level decreased in the maternal serum and in the cord blood, and the thyrotropin level also became lower in the epileptic mother taking antiepileptic drugs. The growth hormone level in the umbilical vein sample of the epileptic mother was lower than that in the controls. The correlations between the head circumference of an infant at delivery and the decreased levels of the hormones seemed to indicate that a decrease in the thyroxine level, caused by antiepileptic drugs, produced the foetal head growth retardation.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D010908 Pituitary Hormones, Anterior Hormones secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Structurally, they include polypeptide, protein, and glycoprotein molecules. Adenohypophyseal Hormones,Anterior Pituitary Hormones,Hormones, Adenohypophyseal,Hormones, Anterior Pituitary
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D005317 Fetal Growth Retardation Failure of a FETUS to attain expected GROWTH. Growth Retardation, Intrauterine,Intrauterine Growth Retardation,Fetal Growth Restriction,Intrauterine Growth Restriction
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic

Related Publications

S Kaneko, and T Hirano, and Y Fukushima, and T Sato, and Y Nomura, and S Shinagawa, and Y Ogawa
July 1982, No to shinkei = Brain and nerve,
S Kaneko, and T Hirano, and Y Fukushima, and T Sato, and Y Nomura, and S Shinagawa, and Y Ogawa
August 1977, The Journal of clinical endocrinology and metabolism,
S Kaneko, and T Hirano, and Y Fukushima, and T Sato, and Y Nomura, and S Shinagawa, and Y Ogawa
July 1981, Lancet (London, England),
S Kaneko, and T Hirano, and Y Fukushima, and T Sato, and Y Nomura, and S Shinagawa, and Y Ogawa
March 1980, Acta endocrinologica,
S Kaneko, and T Hirano, and Y Fukushima, and T Sato, and Y Nomura, and S Shinagawa, and Y Ogawa
January 1980, Minerva pediatrica,
S Kaneko, and T Hirano, and Y Fukushima, and T Sato, and Y Nomura, and S Shinagawa, and Y Ogawa
September 1985, Human nutrition. Clinical nutrition,
S Kaneko, and T Hirano, and Y Fukushima, and T Sato, and Y Nomura, and S Shinagawa, and Y Ogawa
January 1980, Endocrinologie,
S Kaneko, and T Hirano, and Y Fukushima, and T Sato, and Y Nomura, and S Shinagawa, and Y Ogawa
January 1980, Endocrinologie,
S Kaneko, and T Hirano, and Y Fukushima, and T Sato, and Y Nomura, and S Shinagawa, and Y Ogawa
October 2001, Clinical chemistry and laboratory medicine,
S Kaneko, and T Hirano, and Y Fukushima, and T Sato, and Y Nomura, and S Shinagawa, and Y Ogawa
January 1987, Reproduction, nutrition, developpement,
Copied contents to your clipboard!